Abionyx Pharma SA
F:609
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abionyx Pharma SA
F:609
|
FR |
|
C
|
Carlisle Companies Inc
F:CLE
|
US |
|
C
|
Carlsberg A/S
XMUN:CBGB
|
DK |
|
F
|
Franco-Nevada Corp
F:3FO
|
CA |
|
M
|
MBB SE
XMUN:MBB
|
DE |
|
I
|
IDT Corp
XMUN:IDC2
|
US |
|
China Construction Bank Corp
SSE:601939
|
CN |
|
J
|
JAFCO Group Co Ltd
XBER:JAF
|
JP |
|
X
|
Xinjiang Goldwind Science & Technology Co Ltd
XBER:CXGH
|
CN |
|
Symbotic Inc
NASDAQ:SYM
|
US |
Shareholder Yield
Current shareholder yield for 
Abionyx Pharma SA is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Abionyx Pharma SA
| Average Annual Return | 18.5% |
| Standard Deviation of Annual Returns | 77.73% |
| Max Drawdown | -72% |
| Market Capitalization | 82.8m EUR |
| Shares Outstanding | 34 665 900 |
| Percentage of Shares Shorted |
N/A
|
